{ "item_title" : "Blue Book on the Survival Status of Chinese Patients with HR-Positive, HER2-Negative Advanced Breast Cancer (2024)/中", "item_author" : [" 吴炅 主编 "], "item_description" : "In the long history of medicine, breast cancer, as one of the most common malignant tumors among women worldwide, has consistently been a major focus of treatment and research in the global medical field. With continuous advancements in medical technology, the survival prognosis for breast cancer patients has greatly improved. Even so, the complexity and challenges of treating patients with HR+/HER2- advanced breast cancer persist, driving us to continuously explore more effective treatment strategies and management models, particularly with regard to patients' quality of life. 在医学的长河中，乳腺癌作为全球女性最常见的恶性肿瘤之一，其治疗和研究一直是全球医疗领域关注的重点。随着医疗技术的不断进步，乳腺癌患者的生存预后得到了很大的改善。即便如此，对于HR+/HER2-晚期乳腺癌患者治疗的复杂性和挑战依然存在，这促使我们不断探索更为有效的治疗方案和管理模式，尤其是患者生活质量方面。", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/7/54/787/104/7547871046_b.jpg", "price_data" : { "retail_price" : "20.99", "online_price" : "20.99", "our_price" : "20.99", "club_price" : "20.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }

Overview

Customers Also Bought

Details